Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
C-A Yang, S-T Huang & B-L Chiang. (2014) Association of NLRP3 and CARD8 genetic polymorphisms with juvenile idiopathic arthritis in a Taiwanese population. Scandinavian Journal of Rheumatology 43:2, pages 146-152.
Read now
Read now
Articles from other publishers (25)
Rubén Queiro, Elena Aurrecoechea, Sara Alonso Castro, Ignacio Villa Blanco, Anahy Brandy-Garcia & Raquel Linge. (2023) Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile. Frontiers in Immunology 14.
Crossref
Crossref
Chrysoula G. Gialouri, Maria Pappa, Gerasimos Evangelatos, Elena Nikiphorou & George E. Fragoulis. (2023) Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review. Autoimmunity Reviews 22:7, pages 103357.
Crossref
Crossref
Philippa D. K. Curry, Andrew P. Morris, Anne Barton & James Bluett. (2022) Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?. The Pharmacogenomics Journal 23:1, pages 1-7.
Crossref
Crossref
Enriqueta Vallejo-Yagüe, Theresa Burkard, Raphael Micheroli & Andrea Michelle Burden. (2022) Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort. BMJ Open 12:9, pages e061474.
Crossref
Crossref
James M Gwinnutt, Maud Wieczorek, Giulio Cavalli, Andra Balanescu, Heike A Bischoff-Ferrari, Annelies Boonen, Savia de Souza, Annette de Thurah, Thomas E Dorner, Rikke Helene Moe, Polina Putrik, Javier Rodríguez-Carrio, Lucía Silva-Fernández, Tanja Stamm, Karen Walker-Bone, Joep Welling, Mirjana I Zlatković-Švenda, Francis Guillemin & Suzanne M M Verstappen. (2022) Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. RMD Open 8:1, pages e002168.
Crossref
Crossref
Christine Ballegaard, Marie Skougaard, Jørgen Guldberg-Møller, Christoffer V Nissen, Kirstine Amris, Tanja S Jørgensen, Lene Dreyer & Lars E Kristensen. (2021) Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study. Rheumatology 60:7, pages 3289-3300.
Crossref
Crossref
Jordi Gratacós, Eva Galíndez & Teresa Otón. (2021) Is obesity a predictor for lack of response to treatment in psoriatic arthritis? A systematic review. Reumatología Clínica (English Edition) 17:5, pages 268-278.
Crossref
Crossref
Jordi Gratacós, Eva Galíndez & Teresa Otón. (2021) ¿Es la obesidad un factor predictivo de falta de respuesta al tratamiento en la artritis psoriásica? Actualización de una revisión sistemática. Reumatología Clínica 17:5, pages 268-278.
Crossref
Crossref
Eric Toussirot. (2020) The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition. Metabolites 10:3, pages 107.
Crossref
Crossref
Natalie Boytsov, Xiang Zhang, Kristin A. Evans & Barbara H. Johnson. (2019) Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis. PharmacoEconomics - Open 4:1, pages 105-117.
Crossref
Crossref
Penelope A. Hirt, David E. Castillo, Gil Yosipovitch & Jonette E. Keri. (2019) Skin changes in the obese patient. Journal of the American Academy of Dermatology 81:5, pages 1037-1057.
Crossref
Crossref
Juan Shan & Jiabi Zhang. (2019) Influence de l’obésité sur l’efficacité de différents agents biologiques dans les maladies inflammatoires : revue systématique et méta-analyse. Revue du Rhumatisme 86:4, pages 326-336.
Crossref
Crossref
YX, Lee, YH Kwan, KK Lim, CS Tan, NL Lui, JK Phang, EH Chew, T Ostbye, J Thumboo & W Fong. (2019) A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases. Singapore Medical Journal 60:6, pages 270-280.
Crossref
Crossref
Musaab Elmamoun, Ying Ying Leung, Denis O’Sullivan, Ingrid Steinkoenig, Vinod Chandran, Dafna D. Gladman, Oliver M. FitzGerald, Ana-Maria Orbai & Lihi Eder. (2019) Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set. The Journal of Rheumatology 46:3, pages 266-273.
Crossref
Crossref
Juan Shan & Jiabi Zhang. (2019) Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis. Joint Bone Spine 86:2, pages 173-183.
Crossref
Crossref
Agata Schramm-Luc, Jolanta Schramm, Mateusz Siedliński, Tomasz J. Guzik & Bogdan Batko. (2018) Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells. Clinical Rheumatology 37:6, pages 1597-1604.
Crossref
Crossref
Siddharth Singh, Antonio Facciorusso, Abha G. Singh, Niels Vande Casteele, Amir Zarrinpar, Larry J. Prokop, Eduardo L. Grunvald, Jeffrey R. Curtis & William J. Sandborn. (2018) Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis. PLOS ONE 13:5, pages e0195123.
Crossref
Crossref
Roberta Lupoli, Paolo Pizzicato, Antonella Scalera, Pasquale Ambrosino, Manuela Amato, Rosario Peluso & Matteo Nicola Dario Di Minno. (2016) Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Pil Højgaard, Bente Glintborg, Lars Erik Kristensen, Bjorn Gudbjornsson, Thorvardur Jon Love & Lene Dreyer. (2016) The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries. Rheumatology 55:12, pages 2191-2199.
Crossref
Crossref
Eva Galíndez & Loreto Carmona. (2016) Is Obesity in Psoriatic Arthritis Associated With a Poorer Therapeutic Response and More Adverse Effects of Treatment With an Anchor Drug?. Reumatología Clínica (English Edition) 12:6, pages 307-312.
Crossref
Crossref
Eva Galíndez & Loreto Carmona. (2016) ¿Se asocia la obesidad en la artritis psoriásica a una menor respuesta terapéutica y más efectos adversos con el tratamiento de fondo?. Reumatología Clínica 12:6, pages 307-312.
Crossref
Crossref
Florenzo Iannone, Giuseppe Lopalco, Donato Rigante, Ida Orlando, Luca Cantarini & Giovanni Lapadula. (2016) Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy. Autoimmunity Reviews 15:5, pages 447-450.
Crossref
Crossref
Florenzo Iannone, Rosalinda Fanizzi, Antonella Notarnicola, Crescenzio Scioscia, Maria Grazia Anelli & Giovanni Lapadula. (2015) L’obésité diminue le maintien thérapeutique des traitements biologiques de seconde ligne après échec d’un anti-TNF de première ligne au cours de la polyarthrite rhumatoïde. Revue du Rhumatisme 82:4, pages 230-235.
Crossref
Crossref
Florenzo Iannone, Rosalinda Fanizzi, Antonella Notarnicola, Crescenzio Scioscia, Maria Grazia Anelli & Giovanni Lapadula. (2015) Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients. Joint Bone Spine 82:3, pages 187-191.
Crossref
Crossref
Koichi Yanaba, Yoshinori Umezawa, Toshihiro Ito, Mitsuha Hayashi, Sota Kikuchi, Osamu Fukuchi, Hidehisa Saeki & Hidemi Nakagawa. (2014) Impact of obesity on the efficacy of ustekinumab in Japanese patients with psoriasis: a retrospective cohort study of 111 patients. Archives of Dermatological Research 306:10, pages 921-925.
Crossref
Crossref